Dabur India Ltd vs Sampre Nutritions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 06, 2026

Key Highlights

The Latest Trading Price of Dabur India Ltd is ₹ 388.4 as of 06 Oct 15:30 . The P/E Ratio of Dabur India Ltd changed from 56.4 on March 2021 to 38.4 on March 2026 . This represents a CAGR of -6.21% over 6 yearsThe P/E Ratio of Sampre Nutritions Ltd changed from 178.9 on March 2023 to 54.1 on March 2026 . This represents a CAGR of -25.84% over 4 years The Market Cap of Dabur India Ltd changed from ₹ 95564 crore on March 2021 to ₹ 72792 crore on March 2026 . This represents a CAGR of -4.44% over 6 yearsThe Market Cap of Sampre Nutritions Ltd changed from ₹ 62.7 crore on March 2023 to ₹ 164.46 crore on March 2026 . This represents a CAGR of 27.26% over 4 years The revenue of Dabur India Ltd for the Jun '26 is ₹ 3936 crore as compare to the Mar '26 revenue of ₹ 3213 crore. This represent the growth of 22.53% The revenue of Sampre Nutritions Ltd for the Jun '26 is ₹ 14.92 crore as compare to the Mar '26 revenue of ₹ 15.77 crore. This represent the decline of -5.39% The ebitda of Dabur India Ltd for the Jun '26 is ₹ 913.45 crore as compare to the Mar '26 ebitda of ₹ 635.85 crore. This represent the growth of 43.66% The ebitda of Sampre Nutritions Ltd for the Jun '26 is ₹ 1.57 crore as compare to the Mar '26 ebitda of ₹ 1.1 crore. This represent the growth of 42.73% The net profit of Dabur India Ltd changed from ₹ 494.35 crore to ₹ 586.16 crore over 9 quarters. This represents a CAGR of 7.87% The net profit of Sampre Nutritions Ltd changed from ₹ 0.1 crore to ₹ 0.7 crore over 9 quarters. This represents a CAGR of 137.46% The Dividend Payout of Dabur India Ltd changed from 60.75 % on March 2021 to 98.13 % on March 2026 . This represents a CAGR of 8.32% over 6 yearsThe Dividend Payout of Sampre Nutritions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Dabur India Ltd

Dabur India Limited is one of the leading FMCG Companies in India and a global leader in Ayurveda with a portfolio of over 250 Herbal and Ayurvedic products.
The Company operate in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care and Foods.
Their FMCG portfolio includes five flagship brands with distinct brand identities, 'Dabur' as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Real for fruit juices and beverages and Fem for fairness bleaches and skin care products. The Company operates through three Strategic Business Units, Consumer Care Division (CCD), International Business Division (IBD) and Consumer Health Division (CHD).
Their CCD business is divided into four key portfolios: healthcare, personal care, home care and foods.

About Sampre Nutritions Ltd

Sampre Nutritions Limited., incorporated in 1991 was promoted by The Gurbani Group, having its works at Medchal, in Andhra Pradesh.
The Company is into the activity of manufacturing of Sugar Candies.
The Company has been manufacturing candy products for its major customer, Cadbury India Ltd since August 1996.
In 2000, it entered into agreement to manufacture 'DAIRY MILK ECLAIRS'. During 1999, the Company commissioned two new projects for manufacture of Jelly in cups under the brand name 'GOLLUM' and 'Mr POPS'. The company was also into the production of HERICOF Cough Lozenges for Ranbaxy Laboratories Ltd, whereby it manufactures CHESTO cough drops for export to its customer 'The Maharaja Organisation Ltd' of Sri Lanka. During 2000, the Company got a major break-through during as it has commenced supplying confectionery products from April 2000 to the various depots of the Indian Airlines across the country The Company launched 6 flavors of Hard Boiled Candy under 'Sampre' Brand in first phase during the year 2018.

FAQs for the comparison of Dabur India Ltd and Sampre Nutritions Ltd

Which company has a larger market capitalization, Dabur India Ltd or Sampre Nutritions Ltd?

Market cap of Dabur India Ltd is 68,900 Cr while Market cap of Sampre Nutritions Ltd is 57 Cr

What are the key factors driving the stock performance of Dabur India Ltd and Sampre Nutritions Ltd?

The stock performance of Dabur India Ltd and Sampre Nutritions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dabur India Ltd and Sampre Nutritions Ltd?

As of October 6, 2026, the Dabur India Ltd stock price is INR ₹388.4. On the other hand, Sampre Nutritions Ltd stock price is INR ₹6.01.

How do dividend payouts of Dabur India Ltd and Sampre Nutritions Ltd compare?

To compare the dividend payouts of Dabur India Ltd and Sampre Nutritions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.